Jazdarehee Aria, Huget-Penner Sawyer, Pawlowska Monika
Department of Medicine and Faculty of Medicine, University of British Columbia, British Columbia, Canada.
Division of Endocrinology and Metabolism, Fraser Health Authority, British Columbia, Canada.
Endocrinol Diabetes Metab Case Rep. 2022 Feb 1;2022. doi: 10.1530/EDM-21-0100.
Obstructive sleep apnea (OSA) is a condition of intermittent nocturnal upper airway obstruction. OSA increases sympathetic drive which may result in clinical and biochemical features suggestive of pheochromocytoma. We present the case of a 65-year-old male with a 2.9-cm left adrenal incidentaloma on CT, hypertension, symptoms of headache, anxiety and diaphoresis, and persistently elevated 24-h urine norepinephrine (initially 818 nmol/day (89-470)) and normetanephrine (initially 11.2 µmol/day (0.6-2.7)). He was started on prazosin and underwent left adrenalectomy. Pathology revealed an adrenal corticoadenoma with no evidence of pheochromocytoma. Over the next 2 years, urine norepinephrine and normetanephrine remained significantly elevated with no MIBG avid disease. Years later, he was diagnosed with severe OSA and treated with continuous positive airway pressure. Urine testing done once OSA was well controlled revealed complete normalization of urine norepinephrine and normetanephrine with substantial symptom improvement. It was concluded that the patient never had a pheochromocytoma but rather an adrenal adenoma with biochemistry and symptoms suggestive of pheochromocytoma due to untreated severe OSA. Pseudo-pheochromocytoma is a rare presentation of OSA and should be considered on the differential of elevated urine catecholamines and metanephrines in the right clinical setting.
Obstructive sleep apnea (OSA) is a common condition among adults. OSA may rarely present as pseudo-pheochromocytoma with symptoms of pallor, palpitations, perspiration, headache, or anxiety. OSA should be considered on the differential of elevated urine catecholamines and metanephrines, especially in patients with negative metaiodobenzylguanidine (MIBG) scan results.
阻塞性睡眠呼吸暂停(OSA)是一种夜间间歇性上气道阻塞疾病。OSA会增加交感神经驱动力,这可能导致出现提示嗜铬细胞瘤的临床和生化特征。我们报告一例65岁男性病例,其CT检查发现左肾上腺有一个2.9厘米的意外瘤,伴有高血压、头痛、焦虑和多汗症状,24小时尿去甲肾上腺素(最初为818纳摩尔/天(89 - 470))和去甲变肾上腺素(最初为11.2微摩尔/天(0.6 - 2.7))持续升高。他开始服用哌唑嗪并接受了左肾上腺切除术。病理检查显示为肾上腺皮质腺瘤,无嗜铬细胞瘤证据。在接下来的2年里,尿去甲肾上腺素和去甲变肾上腺素仍显著升高,无间碘苄胍(MIBG)摄取阳性病变。数年后,他被诊断为重度OSA,并接受持续气道正压通气治疗。OSA得到良好控制后进行的尿液检测显示,尿去甲肾上腺素和去甲变肾上腺素完全恢复正常,症状也有显著改善。结论是该患者从未患过嗜铬细胞瘤,而是患有肾上腺腺瘤,因其未治疗的重度OSA导致出现提示嗜铬细胞瘤的生化指标和症状。假性嗜铬细胞瘤是OSA的一种罕见表现,在正确的临床背景下,当尿儿茶酚胺和甲变肾上腺素升高时,应考虑到这一鉴别诊断。
阻塞性睡眠呼吸暂停(OSA)在成年人中很常见。OSA很少表现为假性嗜铬细胞瘤,伴有面色苍白、心悸、出汗、头痛或焦虑等症状。在尿儿茶酚胺和甲变肾上腺素升高的鉴别诊断中应考虑OSA,尤其是在间碘苄胍(MIBG)扫描结果为阴性的患者中。